Features

• The BinaxNOW COVID-19/Flu A&B is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid protein directly in anterior nasal swab samples from individuals with signs and symptoms of respiratory tract infection
• For Professional use
• All negative results are presumptive and should be confirmed with an FDA-cleared molecular assay when determined to be appropriate by a healthcare provider
• Negative results do not rule out infection with influenza, SARS-CoV-2, or other pathogens
• Individuals who test negative and experience continued or worsening respiratory symptoms, such as fever, cough and/or shortness of breath, should seek follow-up care from their healthcare provider
• Positive results do not rule out co-infection with other respiratory pathogens, and therefore do not substitute for a visit to a healthcare provider or appropriate follow-up
• For use with Anterior Nasal Swab Specimens Only
• For use with BinaxNOW COVID-19/Flu A&B Control Swab Kit (20002055) – Not included